COP11 Concludes with Major Decisions on Global Tobacco Control

Nov.24.2025
COP11 Concludes with Major Decisions on Global Tobacco Control
The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on November 22, with 160 Parties adopting major decisions on tobacco and nicotine regulation, environmental protection, sustainable financing, and tobacco industry liability. A landmark decision mandates a complete ban on the use and sale of tobacco and all novel nicotine products across all UN premises worldwide.

Key Points

 

  • Parties invited to consider comprehensive regulation of tobacco and nicotine product components to reduce environmental harm.
  • Domestic resource mobilization reaffirmed as essential for sustainable tobacco control funding.
  • Strengthened implementation of Article 19 on tobacco industry liability encouraged.
  • UN-wide ban adopted on all tobacco and nicotine products, including heated tobacco, ENDS/ENNDS, nicotine pouches, and disposables.
  • Parties urged to reinforce protections against tobacco industry interference (Article 5.3).
  • COP12 to be held in Yerevan, Armenia, in 2027.

 


 

2Firsts, 24 November 2025 — According to an official WHO news release,The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (WHO FCTC) concluded in Geneva from 17–22 November 2025. A total of 160 Parties gathered to discuss global tobacco control measures under one of the most widely embraced UN treaties dedicated to ending the global tobacco epidemic.

 

Andrew Black, Acting Head of the Secretariat of the WHO FCTC, said the decisions adopted will help save millions of lives in the years ahead and protect the planet from the environmental harms caused by tobacco.

 

Key agenda items addressed included the environmental and health impacts of tobacco, including measures to prevent and manage waste from tobacco and nicotine products and related electronic devices. Trillions of cigarette butts containing plastic filters pollute the environment annually.

 

A decision was adopted inviting Parties to consider comprehensive regulatory options for tobacco and nicotine product components and related external elements that increase environmental harms.

 

Another decision reaffirmed domestic resource mobilization as a core strategy for achieving sustainable and predictable funding for national tobacco control programmes.

 

The meeting also addressed Article 19 of the WHO FCTC, which relates to criminal and civil liability for tobacco-related harms. Parties adopted a decision encouraging strengthened implementation of this article through enhanced cooperation.

 

Forward-looking tobacco control measures under Article 2.1 were also discussed, including approaches that go beyond the Convention’s basic requirements.

 

A landmark decision was adopted calling for a complete ban on the use and sale of all tobacco products and all novel and emerging nicotine products—including heated tobacco products, ENDS/ENNDS, nicotine pouches, and disposable ENDS—across all UN indoor and outdoor premises worldwide.

 

Agenda item 4.5 addressed measures to prevent and reduce nicotine addiction and the need to protect such measures from tobacco industry interference, particularly regarding new products marketed with unproven health claims.

 

More than 1,600 participants registered for COP11, including Parties, NGOs, and youth observers. It was also announced that COP12 and MOP5 will be held in Yerevan, Armenia, in 2027.

 

The Meeting of the Parties (MOP) to the Protocol to Eliminate Illicit Trade in Tobacco Products will convene in Geneva on 24–26 November to discuss strategies to advance implementation of the Protocol.

 

Image source: WHO Framework Convention on Tobacco Control

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spain’s Popular Party and Socialist Party reached an agreement in the Joint Congress-Senate Commission for the Study of Addiction Problems and approved a non-binding motion calling for the sale of e-cigarettes, nicotine pouches and related products to be limited to authorized and controlled channels, such as tobacco shops and specialized stores, while excluding internet sales and general retail outlets.
Apr.27 by 2FIRSTS.ai
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia will strengthen surveillance of vapes amid growing concerns over drug-laced e-cigarettes. The National Food and Drug Monitoring Agency, or BPOM, will soon take charge of monitoring nationwide vape distribution and said it will work with the National Narcotics Agency, or BNN. BNN recently floated a plan to completely ban e-cigarettes, saying a total ban was the only way to prevent liquid narcotics.
May.11 by 2FIRSTS.ai
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai